Better Choice FY2023 revenue falls 29% YoY to $38.6M; gross margin up to 31%, net loss narrows 42%

SRx Health Solutions, Inc.

2024-Q1 EPS reported -$3.60 revenue$1,200,000

Net sales $38.6M vs $54.7M in 2022; decline driven by international stock normalization and exit of unprofitable accounts.
Gross margin improved 300 bps to 31% due to strategic pricing and 3% reduction in input costs.
Net loss improved 42% to $22.8M; EPS improved 45% to ($32.29) from ($58.93).
Adjusted EBITDA improved 32% to ($8.0M); operating loss improved 45% to $21.2M.
Q4 2023 operating loss improved 47% YoY to $12.7M; adjusted EBITDA improved 30% to ($3.4M).

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.7

SRx Health Solutions, Inc. reported financial results for the fourth quarter and year ended December 31, 2023.

Period: the fourth quarter and year ended December 31, 2023
Result: reported results

Exact text from the filing

Better Choice Company Inc., a Delaware corporation (“the Company”), announced its financial results for the fourth quarter and year ended December 31, 2023.

View on SEC.gov

516 earnings releases filed in the last 30 days. Browse all earnings releases →

SRx Health Solutions, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-015044

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.